Of the five studies examining patients with cardiovascular disease and diabetes, three examined the effects of medications to reduce risk of vascular outcomes (ACE-inhibitor, simvastatin, and cilostazol) and found no differences according to the presence or absence of DM [39]–[41]. Here, ACE is linked to cardiovascular disorder.